Current Portfolio
|
Under Development

For full up to date information about our dossiers under development please
contact us at info@tamarang.es, or call us on +34 932 724 400.

Everolimus 2.5, 5, 7.5 & 10 mg tablets:
CTD dossier available in Q1 2017

Gefitinib 250 mg film-coated tablets:
CTD dossier available in Q1 2018

Sugammadex 100 mg solution for injection (2 & 5 ml):
CTD dossier available in Q1 2018

Abiraterone 250 mg tablets:
CTD dossier available in Q2 2018

Bortezomib 1 & 3.5 mg powder for solution for injection:
CTD dossier available in Q2 2018

Fosaprepitant 150 mg powder for solution for injection:
CTD dossier available in Q1 2018